Servei d'Aparell Digestiu, Hospital Universitari Vall d'Hebron, Barcelona, España; Exocrine Pancreas Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, España; Universitat Autònoma de Barcelona, Barcelona, España; CIBERehd, Instituto de Salud Carlos III, Madrid, España.
Servei de Radiologia, Centre de Diagnòstic per la Imatge Clínic, Hospital Clínic, Barcelona, España; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, España.
Gastroenterol Hepatol. 2022 Mar;45(3):231-248. doi: 10.1016/j.gastrohep.2021.05.017. Epub 2021 Jun 19.
Chronic pancreatitis is a chronic fibroinflammatory disease of the pancreas with prevalence around 50 cases per 100,000 inhabitants. It appears to originate from diverse and yet mixed etiological factors. It shows highly variable presenting features, complication types and disease progression rates. Treatment options are as wide as the multiple personalized scenarios the disease might exhibit at a given time point. Some medical societies have developed guidelines for diagnosis and treatment based on scientific evidence. Although these efforts are to be acknowledged, the gathered level of evidence for any topic is usually low and, therefore, recommendations tend to be vague or weak. In the present series of position papers on chronic pancreatitis from the Societat Catalana de Digestologia and the Societat Catalana de Pàncrees we aimed at providing defined position statements for the clinician based on updated review of published literature and on interdisciplinary expert agreement. The final goal is to propose the use of common terminology and rational diagnostic/therapeutic circuits based on current knowledge. To this end 51 sections related to chronic pancreatitis were reviewed by 21 specialists from 6 different fields to generate 88 statements altogether. Statements were designed to harmonize concepts or delineate recommendations. Part 1 of this paper series discusses topics on aetiology and diagnosis of chronic pancreatitis. Main clinical features are abdominal pain, exocrine and endocrine insufficiency and symptoms derived from complications. Some patients remain symptom-free. Diagnosis (definitive, probable or uncertain) should be based on objective data obtained from imaging, histology, or functional tests.
慢性胰腺炎是一种胰腺的慢性纤维炎症性疾病,其患病率约为每 10 万人中有 50 例。它似乎源自多种且混合的病因因素。它表现出高度可变的临床表现、并发症类型和疾病进展速度。治疗选择与疾病在特定时间点可能表现出的多种个性化情况一样广泛。一些医学协会已经根据科学证据制定了诊断和治疗指南。尽管这些努力值得认可,但任何主题的证据水平通常都较低,因此建议往往模糊或薄弱。在本系列来自加泰罗尼亚消化病学会和加泰罗尼亚胰腺学会的关于慢性胰腺炎的立场文件中,我们旨在根据已发表文献的最新综述和跨学科专家共识,为临床医生提供明确的立场声明。最终目标是根据现有知识提出使用通用术语和合理的诊断/治疗方案。为此,来自 6 个不同领域的 21 名专家审查了与慢性胰腺炎相关的 51 个部分,共生成了 88 条声明。声明旨在协调概念或划定建议。本论文系列的第 1 部分讨论了慢性胰腺炎的病因和诊断主题。主要临床特征是腹痛、外分泌和内分泌功能不全以及并发症引起的症状。一些患者无症状。诊断(明确、可能或不确定)应基于从影像学、组织学或功能检查中获得的客观数据。